HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hisamitsu Pharmaceutical Co.,Inc.

https://global.hisamitsu/

Latest From Hisamitsu Pharmaceutical Co.,Inc.

Salonpas Spreads Into OTC Diclofenac Arthritis Gel

Hisamitsu America launches Salonpas Arthritis Pain Relief Gel with same active ingredient, diclofenac sodium 1% gel, that became available OTC for the first time in the US in 2020 with GSK’s Voltaren Arthritis Pain formulation.

OTC Devices Prescription To Otc Switch

In GSK Challenge Of Salonpas Claims, NAD Embarks On Review Of Unchartered Argument

Hisamitsu America’s severity of pain claims for Salonpas challenged by GSK are more nuanced than what label indications support, but touting its regulatory approval doesn’t convey a message that other products aren’t subject to as rigorous pre-market evaluations.

Ad Complaints OTC Drugs

UK Marketing: Sanofi Launches Buscomint, New Releases From Salonpas and Nailner

The latest OTC launches in the UK, including Buscomint from Sanofi, Salonpas Gel-Patch from Hisamitsu and Nailner Active Cover from Karo.

Innovation Launches

Market Brief: Sales Of Patches To Treat Neurological Disorders Will See Fastest Growth In Global Transdermal Patch Market

The overall transdermal patch market is expected to grow at a CAGR of 2.4% by 2024. Patches to treat neurological disorders will see the fastest growth while pain-management patches will see the most sales.

Market Intelligence Innovation
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • OTC, Consumer
    • Drug Delivery
      • Transdermal
  • Other Names / Subsidiaries
    • CRCC Media Co.,Ltd. (Fukuoka)
    • Saga City-Vision Co.,Ltd. (Saga)
    • Taiyo Co.,Ltd (Saga)
    • Kyudo Co.,Ltd (Saga)
    • Hisamitsu Agency Co.,Ltd. (Fukuoka)
    • Hisamitsu U.S., Inc.
    • Hisamitsu America, Inc.
    • Noven Pharmaceuticals, Inc.
    • Hisamitsu Farmaceutica do Brasil Ltda.
    • Hisamitsu UK Ltd.
    • Hisamitsu Italia S.r.l.
    • Hisamitsu Vietnam Pharmaceutical Co.,Ltd.
    • Hisamitsu Pharmaceutical(China)Co.,Ltd.
    • Hisamitsu Pharmaceutical Technology Consulting(Beijing) Co.,Ltd.
    • Hisamitsu Pharmaceutical (Hong Kong)Co.,Ltd.
    • PT. Hisamitsu Pharma Indonesia
UsernamePublicRestriction

Register